Swiss - Delayed Quote CHF
Molecular Partners AG (MOLN.SW)
3.4400
+0.0750
+(2.23%)
At close: May 9 at 5:31:16 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | -1.52 | -1.47 |
| Low Estimate | 0 | 0 | -1.6 | -2 |
| High Estimate | 0 | 0 | -1.45 | -0.93 |
| Year Ago EPS | -- | -- | -- | -1.52 |
Revenue Estimate
| Currency in CHF | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 3 | 2 |
| Avg. Estimate | -- | -- | 666.67k | 11.16M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 2M | 22.32M |
| Year Ago Sales | 2.74M | -- | 4.97M | 666.67k |
| Sales Growth (year/est) | -100.00% | -- | -86.59% | 1,574.10% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.52 | -1.47 |
| 7 Days Ago | 0 | 0 | -1.6 | -1.62 |
| 30 Days Ago | 0 | 0 | -2.05 | -1.92 |
| 60 Days Ago | 0 | 0 | -2.05 | -1.97 |
| 90 Days Ago | 0 | 0 | -2.05 | -1.97 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MOLN.SW | -- | -- | -- | 3.80% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Related Tickers
4576.T D. Western Therapeutics Institute, Inc.
101.00
+1.00%
NWRN.SW Newron Pharmaceuticals S.p.A.
8.24
+2.74%
2197.HK Clover Biopharmaceuticals, Ltd.
0.199
-1.97%
BSLN.SW Basilea Pharmaceutica AG
44.40
+0.34%
XLS.SW Xlife Sciences AG
20.50
-2.84%
SANN.SW Santhera Pharmaceuticals Holding AG
13.18
-0.15%
IDIA.SW Idorsia Ltd
1.2820
-2.88%
BCAX Bicara Therapeutics Inc.
12.97
-1.22%
IMAB I-Mab
0.8800
0.00%
TRAW Traws Pharma, Inc.
1.3300
-5.00%